|
|
|
42
|
1134BD
|
ATORVASTATIN 80MG TAB (MOR)
|
ATORVASTATIN
|
ATORVASTATIN
|
30'S
|
A
|
3.04
|
0.10
|
TAB
|
30
|
BLIS
|
MOR
|
MORACEAE
|
CWS
|
CAPSULE WHOLESALE
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
41
|
1134W
|
ATORVASTATIN 80MG TAB (FSB)
|
ATORVASTATIN
|
ATORVASTATIN
|
10X10
|
A
|
13.59
|
0.1359
|
TAB
|
30
|
BOX
|
FSB
|
FLAGSHIP BIOTECH
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1134Y
|
CRESTOR 40MG TAB (AZN/COL) ROSUVASTATIN
|
ROSUVASTATIN
|
CRESTOR
|
30'S
|
C
|
46.24
|
1.54
|
TABLET
|
0
|
TAB
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
1134Y
|
CRESTOR 40MG TAB (AZN) ROSUVASTATIN (C)
|
ROSUVASTATIN
|
CRESTOR
|
30'S
|
C
|
46.24
|
1.5413
|
TAB
|
30
|
BOX
|
AZN
|
ASTRAZENECA AB
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
42
|
1134Y
|
CRESTOR 40MG TAB (AZN) ROSUVASTATIN
|
ROSUVASTATIN
|
CRESTOR
|
30'S
|
C
|
46.24
|
1.54
|
TAB
|
30
|
BLIS
|
AZN
|
ASTRAZENECA AB
|
COL
|
AVENTA BARBADOS
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
41
|
11519
|
GEMFIBROZIL 300MG TAB (KWA)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
100'S
|
A
|
27.1832
|
0.2718
|
TAB
|
60
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
FIBRIC ACID DERIVATIVES
|
|
|
|
|
42
|
1151B
|
TRILIPIX 135MG DR CAP (ABB) FENOFIBRATE
|
FENOFIBRATE
|
TRILIPIX
|
3X10
|
C
|
89.70
|
2.99
|
CAP
|
0
|
BLIS
|
ABB
|
ABBOTT
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2026-04-01
|
|
|
ORAL
|
0
|
FIBRIC ACID DERIVATIVES
|
|
|
|
|
40
|
11529
|
GEMFIBROZIL 600MG TAB (CIP/AHI)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
60'S
|
B
|
40.86
|
0.68
|
TABLET
|
60
|
TAB
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
11529
|
GEMFIBROZIL 600MG TAB (CIP)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
60'S
|
B
|
40.86
|
0.6809
|
TAB
|
60
|
BOX
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
FIBRIC ACID DERIVATIVES
|
|
|
|
|
42
|
11529
|
GEMFIBROZIL 600MG TAB (CIP)
|
GEMFIBROZIL
|
GEMFIBROZIL
|
60'S
|
C
|
40.91
|
0.68
|
TAB
|
60
|
BLIS
|
CIP
|
CIPLA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
240606
|
FIBRIC ACID DERIVATIVES
|
2026-04-01
|
|
|
ORAL
|
6
|
FIBRIC ACID DERIVATIVES
|
|
|
|
|
40
|
11613
|
HYDRALLAZINE 25MG TAB (REM/SBI)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
10X10
|
A
|
6.28
|
0.06
|
TABLET
|
120
|
TAB
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
240820
|
DIRECT VASODILATOR
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
41
|
11613
|
HYDRALLAZINE 25MG TAB (REM)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
10X10
|
A
|
7.07
|
0.0707
|
TAB
|
120
|
BOX
|
REM
|
REMEDICA LTD
|
SBI
|
MASSY DISTRIBUTION (BDOS) LTD
|
B
|
240820
|
DIRECT VASODILATOR
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT VASODILATOR
|
|
|
|
|
40
|
11615
|
APO-HYDRALLAZINE 25MG TAB (APO/COL)
|
HYDRALLAZINE
|
APO-HYDRALLAZINE
|
100'S
|
A
|
7.20
|
0.07
|
TABLET
|
120
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
240820
|
DIRECT VASODILATOR
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
42
|
11615
|
APO-HYDRALLAZINE 25MG TAB (APO)
|
HYDRALLAZINE
|
APO-HYDRALLAZINE
|
100'S
|
A
|
6.42
|
0.06
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
240820
|
DIRECT VASODILATOR
|
2026-04-01
|
|
|
ORAL
|
6
|
DIRECT VASODILATOR
|
|
|
|
|
41
|
1161AA
|
HYDRALLAZINE 25MG TAB (LDP)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
250'S
|
A
|
14.87
|
0.0595
|
TAB
|
120
|
BOTT
|
LDP
|
LABDHI PHARMA
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
B
|
240820
|
DIRECT VASODILATOR
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT VASODILATOR
|
|
|
|
|
41
|
1161AC
|
APO-HYDRALLAZINE 25MG TAB (APO)
|
HYDRALLAZINE
|
APO-HYDRALLAZINE
|
100'S
|
A
|
6.42
|
0.0642
|
TAB
|
120
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
240820
|
DIRECT VASODILATOR
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
DIRECT VASODILATOR
|
|
|
|
|
42
|
1161AD
|
HYDRALLAZINE 25MG TAB (FSB)
|
HYDRALLAZINE
|
HYDRALLAZINE
|
10X10
|
A
|
6.14
|
0.06
|
TAB
|
120
|
|
FSB
|
FLAGSHIP BIOTECH
|
STO
|
BRYDEN STOKES LTD
|
B
|
240820
|
DIRECT VASODILATOR
|
2026-04-01
|
|
Add to Contract as Cat A
|
ORAL
|
6
|
DIRECT VASODILATOR
|
2026-03-05
|
|
|
|
40
|
11625
|
APO-HYDRALLAZINE 50MG TAB (APO/COL)
|
HYDRALLAZINE
|
APO-HYDRALLAZINE
|
100'S
|
A
|
16.55
|
0.17
|
TABLET
|
60
|
TAB
|
APO
|
APOTEX INC.
|
COL
|
COLLINS LTD
|
B
|
240820
|
DIRECT VASODILATOR
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
42
|
11625
|
APO-HYDRALLAZINE 50MG TAB (APO)
|
HYDRALLAZINE
|
APO-HYDRALLAZINE
|
100'S
|
A
|
13.32
|
0.13
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
COL
|
AVENTA BARBADOS
|
B
|
240820
|
DIRECT VASODILATOR
|
2026-04-01
|
|
|
ORAL
|
6
|
DIRECT VASODILATOR
|
|
|
|
|
41
|
1162AA
|
APO-HYDRALAZINE 50MG TAB (APO)
|
HYDRALLAZINE
|
APO-HYDRALAZINE
|
100'S
|
A
|
13.32
|
0.1332
|
TAB
|
60
|
BOTT
|
APO
|
APOTEX INC.
|
ATB
|
ANSA TRADING BARBADOS LTD
|
B
|
2408
|
HYPOTENSIVE AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
HYPOTENSIVE AGENTS
|
|